Charles River Laboratories (CRL)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 7,528,340 | 8,195,000 | 7,602,770 | 7,024,290 | 5,490,830 |
| Total stockholders’ equity | US$ in thousands | 3,461,500 | 3,596,880 | 2,976,290 | 2,534,820 | 2,114,600 |
| Financial leverage ratio | 2.17 | 2.28 | 2.55 | 2.77 | 2.60 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $7,528,340K ÷ $3,461,500K
= 2.17
The financial leverage ratio of Charles River Laboratories has shown some fluctuation over the past five years. It was 2.60 in December 31, 2020, increased to 2.77 in December 31, 2021, and then decreased to 2.55 in December 31, 2022. Subsequently, it dropped to 2.28 in December 31, 2023, and further decreased to 2.17 in December 31, 2024. Overall, the trend indicates a slight decrease in the financial leverage ratio, which suggests a reduction in the company's reliance on debt to finance its operations over the years. This may imply a strengthening of the company's financial position and potentially lower financial risk associated with debt obligations.
Peer comparison
Dec 31, 2024